TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 25 filers reported holding TRINITY BIOTECH PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $365,000 | -27.4% | 353,086 | -15.1% | 0.32% | -28.0% |
| Q3 2019 | $503,000 | -41.9% | 415,717 | -20.8% | 0.44% | -29.3% |
| Q2 2019 | $866,000 | -45.0% | 524,689 | -5.0% | 0.62% | -36.7% |
| Q1 2019 | $1,574,000 | +20.8% | 552,449 | -2.9% | 0.98% | +20.4% |
| Q4 2018 | $1,303,000 | -41.9% | 569,033 | +1.6% | 0.82% | -2.9% |
| Q3 2018 | $2,241,000 | -12.6% | 560,295 | +9.2% | 0.84% | -16.1% |
| Q2 2018 | $2,565,000 | +22.0% | 513,013 | +25.6% | 1.00% | +18.6% |
| Q1 2018 | $2,103,000 | +1.0% | 408,337 | 0.0% | 0.84% | +3.1% |
| Q4 2017 | $2,083,000 | +11.1% | 408,337 | +22.2% | 0.82% | +11.6% |
| Q3 2017 | $1,875,000 | -2.6% | 334,175 | +4.1% | 0.73% | -2.3% |
| Q2 2017 | $1,926,000 | +0.7% | 320,984 | 0.0% | 0.75% | +9.2% |
| Q1 2017 | $1,913,000 | +0.5% | 320,984 | +16.7% | 0.69% | +6.2% |
| Q4 2016 | $1,904,000 | -65.3% | 275,135 | -33.8% | 0.65% | -67.4% |
| Q3 2016 | $5,491,000 | +16.6% | 415,353 | 0.0% | 1.98% | +12.2% |
| Q2 2016 | $4,710,000 | -2.7% | 415,353 | 0.0% | 1.77% | +0.7% |
| Q1 2016 | $4,843,000 | +0.5% | 415,353 | +1.3% | 1.76% | +0.6% |
| Q4 2015 | $4,820,000 | +39.4% | 409,887 | +35.6% | 1.74% | +31.5% |
| Q3 2015 | $3,458,000 | -34.9% | 302,305 | +2.8% | 1.33% | -32.0% |
| Q2 2015 | $5,310,000 | +21.5% | 294,005 | +29.5% | 1.95% | +15.0% |
| Q1 2015 | $4,371,000 | +1.0% | 227,052 | -8.1% | 1.70% | +4.7% |
| Q4 2014 | $4,326,000 | +7.3% | 247,052 | +12.0% | 1.62% | +8.3% |
| Q3 2014 | $4,031,000 | -5.2% | 220,638 | +19.5% | 1.50% | +4.0% |
| Q2 2014 | $4,252,000 | +8.7% | 184,638 | +14.3% | 1.44% | -4.0% |
| Q1 2014 | $3,913,000 | -3.6% | 161,507 | 0.0% | 1.50% | -24.1% |
| Q4 2013 | $4,060,000 | +15.5% | 161,507 | 0.0% | 1.97% | -2.6% |
| Q3 2013 | $3,514,000 | +29.1% | 161,507 | 0.0% | 2.02% | -0.3% |
| Q2 2013 | $2,721,000 | -0.2% | 161,507 | 0.0% | 2.03% | -9.6% |
| Q1 2013 | $2,726,000 | – | 161,507 | – | 2.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |